Effects of Antiseptics and Fluorides on Orthodontic Archwires
NCT07928596, Not applicable, Completed, Mostafa Kamel Abdel-moez
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Antiseptics and Fluorides on Orthodontic Archwires | ClinicalTrials.gov |
| NCT number | NCT07928596 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 18 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Mostafa Kamel Abdel-moez | ClinicalTrials.gov |
| Conditions | Mechanical Properties, Hardness, Surface Roughness, Friction | ClinicalTrials.gov |
| Interventions | mouthwash with 0.12% chlorhexidine digluconate, flouride mouthwash | ClinicalTrials.gov |
| First posted | 2026-11-10 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Hardness evaluation | 30 days | The hardness test was performed according to the rules and procedures defined by ASTM International. This device is a Vickers microhardness tester manufactured by Wilson Hardness.by applying a 100-g force for 20 seconds. Samples of archwires were cut to approximately 1.5-2 cm in length and fixed with cyanoacrylate on the sample holder. Four indents per sample were made and took the average. | ClinicalTrials.gov |
| Primary | Roughness evaluation | 30 days | Samples of archwires were cut to approximately 1.5-2 cm in length and its surface was cleaned with 95% ethanol. Surface examination was performed under secondary electron imaging (SEI) mode at Accelerating voltage: 5 kV, Working distance (WD): 11 mm, and Magnifications: x200, x1000 The high-resolution SEM images were analyzed using Image J 1.54g software to inspect the surface roughness and quantify the results for further statistical analysis | ClinicalTrials.gov |
| Primary | Modulus of elasticity evaluation | 30 days | The flexural modulus was determined using a universal testing machine (Shimadzu AGS-X2 Series, Shimadzu Corporation, Kyoto, Japan). The three-point bending test was performed in accordance with the recommendations of ISO 15841 for orthodontic wires. A three-point bending fixture consisting of two lower cylindrical supports and a centrally positioned rounded loading nose was mounted on the testing machine. The distance between the supports is fixed and is 10 mm (The span length (L) between supports was set at 10 mm Straight segments (25-30 mm in length) were cut from each archwire . Each specimen was positioned horizontally on the supports, with the 0.022-inch dimension oriented vertically to simulate standard clinical orientation. Careful alignment ensured that the loading nose contacted the midpoint of the specimen. Testing was conducted at a constant crosshead speed of 1 mm/min. | ClinicalTrials.gov |
| Primary | Friction evaluation | 30 days | A metal bracket with a 0.022 inch × 0.028-inch slot, 11° angulation, and 0° torque, was used. Brackets were cemented to rectangular metal block (50 mm × 20 mm × 6 mm). All samples were individually mounted on a computer-controlled materials testing machine (Model LRX-plus; Lloyd Instruments Ltd., Fareham, UK) with a loadcell of 5 kN and data were recorded using computer software (Nexygen-MT; Lloyd Instruments). Samples were secured to the lower fixed compartment of testing machine by tightening screws. A wire was ligated to the bracket and attached to the upper movable compartment of testing machine then pulled out at the crosshead speed of 5 mm/min up to a distance of 5 mm. The maximum static friction force was set as the maximum value during the first movement. The kinetic frictional force was set as the average value of the frictional force when the wire was moved by 1-5 mm recorded using computer software (Nexygen-MT; Lloyd Instruments). Friction force was recorded in gram | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)